Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-08-002789
Filing Date
2008-03-11
Accepted
2008-03-10 21:34:03
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K y50980e10vk.htm 10-K 1030947
2 EX-4.B: FORM OF CLASS B WARRANT y50980exv4wb.htm EX-4.B 40412
3 EX-10.TT: SETTLEMENT AGREEMENT AND MUTUAL RELEASE y50980exv10wtt.htm EX-10.TT 158347
4 EX-21.A: SUBSIDIARIES OF THE REGISTRANT y50980exv21wa.htm EX-21.A 1363
5 EX-23.A: CONSENT OF DELOITTE & TOUCHE LLP y50980exv23wa.htm EX-23.A 2003
6 EX-31.1: CERTIFICATION y50980exv31wa.htm EX-31.A 8268
7 EX-31.B: CERTIFICATION y50980exv31wb.htm EX-31.B 8311
8 EX-32.A: CERTIFICATION y50980exv32wa.htm EX-32.A 3145
9 EX-32.B: CERTIFICATION y50980exv32wb.htm EX-32.B 3124
11 GRAPHIC y50980y5098001.gif GRAPHIC 4990
  Complete submission text file 0000950123-08-002789.txt   1264424
Mailing Address 25 UPTON DRIVE WILMINGTON MA 01887
Business Address 25 UPTON DRIVE WILMINGTON MA 01887 9786577500
DUSA PHARMACEUTICALS INC (Filer) CIK: 0000879993 (see all company filings)

EIN.: 223103129 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31533 | Film No.: 08679241
SIC: 2834 Pharmaceutical Preparations